Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE
Authors
Keywords
AGEs, RAGE, GLAP, Aptamer, Oxidative stress
Journal
Cardiovascular Diabetology
Volume 14, Issue 1, Pages 1
Publisher
Springer Nature
Online
2015-01-08
DOI
10.1186/s12933-014-0162-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression
- (2014) Yuji Ishibashi et al. Cardiovascular Diabetology
- Advanced glycation endproducts trigger autophagy in cadiomyocyte Via RAGE/PI3K/AKT/mTOR pathway
- (2014) Xuwei Hou et al. Cardiovascular Diabetology
- Ratio of Serum Levels of AGEs to Soluble Form of RAGE Is a Predictor of Endothelial Function
- (2014) Masato Kajikawa et al. DIABETES CARE
- DNA aptamer raised against advanced glycation end products inhibits neointimal hyperplasia in balloon-injured rat carotid arteries
- (2014) Ayako Ojima et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- DNA aptamer raised against advanced glycation end products inhibits melanoma growth in nude mice
- (2014) Ayako Ojima et al. LABORATORY INVESTIGATION
- ICAM-1 signaling in endothelial cells
- (2014) Charlotte Lawson et al. Pharmacological Reports
- Pigment epithelium-derived factor (PEDF) binds to caveolin-1 and inhibits the pro-inflammatory effects of caveolin-1 in endothelial cells
- (2013) Takanori Matsui et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor
- (2013) Yuji Ishibashi et al. Cardiovascular Diabetology
- Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathway
- (2013) Qiaojing Qin et al. Cardiovascular Diabetology
- DNA Aptamer Raised Against AGEs Blocks the Progression of Experimental Diabetic Nephropathy
- (2013) Yusuke Kaida et al. DIABETES
- Pigment epithelium-derived factor (PEDF) blocks high glucose-induced inflammatory reactions in endothelial cells through its anti-oxidative properties
- (2013) Sae Nakashima et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells
- (2013) Yuichiro Higashimoto et al. MICROVASCULAR RESEARCH
- Positive Association Between Serum Level of Glyceraldehyde-Derived Advanced Glycation End Products and Vascular Inflammation Evaluated by [18F]Fluorodeoxyglucose Positron Emission Tomography
- (2012) N. Tahara et al. DIABETES CARE
- The modelling of blood coagulation using the quartz crystal microbalance
- (2012) Vitaly Efremov et al. JOURNAL OF BIOMECHANICS
- Serum Levels of Advanced Glycation End Products (AGEs) are Inversely Associated with the Number and Migratory Activity of Circulating Endothelial Progenitor Cells in Apparently Healthy Subjects
- (2011) So Ueda et al. Cardiovascular Therapeutics
- Sitagliptin Augments Protective Effects of GLP-1 against Advanced Glycation End Product Receptor Axis in Endothelial Cells
- (2011) Y. Ishibashi et al. HORMONE AND METABOLIC RESEARCH
- Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product–receptor axis
- (2011) Takanori Matsui et al. PHARMACOLOGICAL RESEARCH
- A dose ranging phase I/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombo - cytopenic purpura
- (2011) Petra Jilma-Stohlawetz et al. THROMBOSIS AND HAEMOSTASIS
- Serum Levels of Advanced Glycation End Products (AGEs) are Independent Correlates of Insulin Resistance in Nondiabetic Subjects
- (2010) Nobuhiro Tahara et al. Cardiovascular Therapeutics
- Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression
- (2009) Yuji Ishibashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Receptor for Advanced Glycation End Products (RAGE): A Novel Therapeutic Target for Diabetic Vascular Complication
- (2008) Sho-ichi Yamagishi et al. CURRENT PHARMACEUTICAL DESIGN
- The Role of AGEs in Cardiovascular Disease
- (2008) Karin Jandeleit-Dahm et al. CURRENT PHARMACEUTICAL DESIGN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More